The research program at PDIC aids in the execution, and evaluation of interventional pain medicine through clinical trials, with the overriding goal of advancing the treatment of pain in patients while making a meaningful difference in their lives and the lives of future patients.
As of the spring of 2020, our team is involved in six clinical research trials with medical device companies including Abbott, Avanos, Medtronic, Nevro, and SGX Medical. David Provenzano, MD is the principal investigator for each of these studies. Five of our clinical trials are based on spinal cord stimulation (SCS) and seek to help patients with chronic pain as a result of conditions including post- laminectomy pain syndrome, chronic back or leg pain, and complex regional pain syndrome (CRPS). The SCS studies explore innovative ways to help increase battery life, decrease levels of pain, and increase efficacy. In addition, new programming parameters are evaluated.
Our research team presently has one clinical trial for genicular nerve radiofrequency ablation (RFA), which is used to treat chronic osteoarthritic knee pain.
While treatments including SCS and RFA are efficacious, we conduct these trials in conjunction with their respective sponsors to advance and improve treatments. Beyond efficacy and safety, we ensure that each treatment is feasible and able to be clinically implemented in a clinical setting.